ClinicalTrials.gg
Sign In

Nerve Degeneration clinical trials

The registry lists 146 studies for Nerve Degeneration across more than 10 countries. 54 are recruiting or about to start. 16 of them are mainly about Nerve Degeneration (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Nerve Degeneration studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
53
Recruiting
46
Status unknown
20
Active, not recruiting
12
Terminated
5
Not yet recruiting
5

Phase

Phase 2
30
Phase 1
16
Phase 3
5
Early Phase 1
2
Phase 4
1

Where

United States
53
Italy
12
United Kingdom
11
Switzerland
8
France
8
Germany
7

Who runs them

Chinese University of Hong Kong (5) · University of Zurich (4) · Clene Nanomedicine (3) · University of Reading (3) · National Institute of Neurological Disorders and Stroke (NINDS) (3) · VA Office of Research and Development (3) · University of Exeter (3) · Johns Hopkins University (3)

What is being tested here

Drugs under test in Nerve Degeneration studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dapansutrile101
AADvac1101
KISS1 protein, human101
Alpha-Linolenic Acid101
Cholecalciferol101
CNM-Au8003
THK5351002
Dextromethorphan012
Memantine012
Idebenone002

Coming up

1phase 3 study under way
22studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 46 Nerve Degeneration studies recruiting now, 24 (52%) set no upper age limit and 8 (17%) stop at 75 or younger. 3 (7%) take children under 18. 0 (0%) are for women only and 1 (2%) for men only; 22 (48%) take healthy volunteers.

Recruiting studies that take each age, of 46
AgeWomenMen
103 (7%)3 (7%)
1824 (52%)24 (52%)
3029 (63%)29 (63%)
4034 (74%)34 (74%)
5041 (89%)41 (89%)
6543 (93%)44 (96%)
7539 (85%)39 (85%)
8529 (63%)29 (63%)

Across all 146 studies, recruiting or not: 32% stop at 75 or younger and 23% at 65; 13% take children; 1% are for women only and 3% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Nerve Degeneration studies take

Of 40 observational studies under Nerve Degeneration, half reached primary completion within 87 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase45 mo9–… · 30 studies——
Observational87 mo33–… · 40 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 146. Browse all 146 → or search them.